Amoroso, Vito
 Distribuzione geografica
Continente #
NA - Nord America 2.082
EU - Europa 955
AS - Asia 291
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 1
SA - Sud America 1
Totale 3.338
Nazione #
US - Stati Uniti d'America 2.072
DE - Germania 322
CN - Cina 193
UA - Ucraina 155
IT - Italia 152
RU - Federazione Russa 79
HK - Hong Kong 73
GB - Regno Unito 62
PL - Polonia 56
FI - Finlandia 52
IE - Irlanda 37
FR - Francia 17
IN - India 12
BE - Belgio 10
CA - Canada 10
AU - Australia 5
SE - Svezia 5
NL - Olanda 4
VN - Vietnam 4
EU - Europa 3
TR - Turchia 3
IR - Iran 2
SG - Singapore 2
BY - Bielorussia 1
CH - Svizzera 1
FK - Isole Falkland (Malvinas) 1
HU - Ungheria 1
JP - Giappone 1
LA - Repubblica Popolare Democratica del Laos 1
MU - Mauritius 1
RO - Romania 1
Totale 3.338
Città #
Fairfield 357
Woodbridge 240
Ashburn 165
Houston 154
Cambridge 134
Seattle 133
Jacksonville 131
Chandler 123
Wilmington 113
Ann Arbor 110
Hong Kong 72
Princeton 65
New York 58
Warsaw 56
Helsinki 43
Beijing 40
Dearborn 37
Dublin 37
Nanjing 28
Brescia 23
Nürnberg 20
Changsha 18
Milan 16
Nanchang 16
Shanghai 16
Des Moines 14
London 12
Hebei 11
San Diego 11
Shenyang 11
Jinan 10
Rome 10
Brussels 9
Jiaxing 8
San Mateo 7
Washington 7
Toronto 6
Los Angeles 5
Ningbo 5
Orange 5
Perugia 5
Boardman 4
Dong Ket 4
Guangzhou 4
Lancaster 4
Naples 4
Rovato 4
Tianjin 4
Alessandria 3
Augusta 3
Barberino di Mugello 3
Canberra 3
Genoa 3
Haikou 3
Hangzhou 3
Hefei 3
Verona 3
Ardabil 2
Bergamo 2
Changchun 2
Chiswick 2
Gradara 2
Hamilton 2
Kilburn 2
Melbourne 2
Melfi 2
Ottawa 2
Pianello del Lario 2
Poli 2
Redwood City 2
San Francisco 2
Zhengzhou 2
Almere Stad 1
Bareggio 1
Cavezzo 1
Cazzago San Martino 1
Charleston 1
Chengdu 1
Cleveland 1
Delhi 1
Dietikon 1
Falkenstein 1
Frankfurt am Main 1
Fuzhou 1
Galati 1
Gavardo 1
Gunzenhausen 1
Hyderabad 1
Islington 1
Kocaeli 1
Kunming 1
Lanzhou 1
Lappeenranta 1
Lviv 1
Mapello 1
Mariano Comense 1
Menen 1
Modugno 1
Mogilëv 1
Monmouth Junction 1
Totale 2.454
Nome #
Comparative efficacy of palbociclib, ribociclib and abemaciclib for ER+ metastatic breast cancer: an adjusted indirect analysis of randomized controlled trials 155
Excess of second tumors in denosumab-treated patients: A metabolic hypothesis 151
Neoadjuvant treatment approach: The rosetta stone for breast cancer? 144
Genetic Polymorphisms as Possible Factors Involved in the Onset of Anthracycline-Induced Cardiomyopathy 140
Testosterone Levels and Prostate Cancer Prognosis: Systematic Review and Meta-analysis 138
Regression of advanced neuroendocrine tumors among patients receiving placebo 135
Should Adjuvant Weekly Paclitaxel Be Considered Less Efficacious Than Anthracyclines Plus Cyclophosphamide for Lower Risk Patients With Early-Stage Breast Cancer? 130
Osimertinib in EGFR Mutation–Positive Advanced NSCLC 127
Outcome of patients with lung adenocarcinoma with transformation to small-cell lung cancer following tyrosine kinase inhibitors treatment: A systematic review and pooled analysis 126
When should everolimus be administered in the natural history of pancreatic neuroendocrine tumors? 122
Pathologic Complete Response As a Potential Surrogate for the Clinical Outcome in Patients With Breast Cancer After Neoadjuvant Therapy: A Meta-Regression of 29 Randomized Prospective Studies. 122
Adjuvant bisphosphonates in patients with breast cancer: Does the potency matter? 120
Exemestane with ovarian suppression in premenopausal breast cancer. 120
Association of Fat Body Mass With Vertebral Fractures in Postmenopausal Women With Early Breast Cancer Undergoing Adjuvant Aromatase Inhibitor Therapy 119
Serum vitamin D and prostate cancer prognosis: The story continues 118
Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors. 117
Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study 113
The involvement of early stage breast cancer patients during oncology consultations in Italy: a multi-centred, randomized controlled trial of a Question Prompt Sheet versus Question Listing 111
Eribulin Treatment in Patients with Liver Metastatic Breast Cancer: Eight Italian Case Reports 108
IFN-α in advanced well-differentiated neuroendocrine tumors: The neglected drug? 104
Systemic therapies in patients with advanced well-differentiated pancreatic neuroendocrine tumors (PanNETs): When cytoreduction is the aim. A critical review with meta-analysis 92
The Spread of SARS-CoV-2 Infection Among the Medical Oncology Staff of ASST Spedali Civili of Brescia: Efficacy of Preventive Measures 87
Eribulin in Heavily Pretreated Metastatic Breast Cancer Patients in the Real World: A Retrospective Study 85
Management of neuroendocrine tumors: State of the art 84
Efficacy of the DigniCap System in preventing chemotherapy-induced alopecia in breast cancer patients is not related to patient characteristics or side effects of the device 58
Efficacy of topic steroids in the management of asthma and chronic obstructive pulmonary disease in advanced non-small cell lung cancer patients during treatment with nivolumab 56
Efficacy of Eribulin mesylate in older patients with breast cancer: A pooled analysis of clinical trial and real-world data 47
Changes in eating habits and food preferences in breast cancer patients undergoing adjuvant chemotherapy 47
Should everolimus be stopped after radiological progression in metastatic insulinoma? A “cons” point of view 42
Sacituzumab govitecan and radiotherapy in metastatic, triple-negative, and BRCA-mutant breast cancer patient with active brain metastases: A case report 40
Outcome of patients with intrathyroidal thymic carcinoma: a pooled analysis 39
The Interaction of Lean Body Mass With Fat Body Mass Is Associated With Vertebral Fracture Prevalence in Women With Early Breast Cancer Undergoing Aromatase Inhibitor Therapy 31
Outcome of Patients With Metastatic Lung Neuroendocrine Tumors Submitted to First Line Monotherapy With Somatostatin Analogs 28
Taste alterations during neo/adjuvant chemotherapy and subsequent follow-up in breast cancer patients: a prospective single-center clinical study 23
Assessment of DXA derived bone quality indexes and bone geometry parameters in early breast cancer patients: A single center cross-sectional study 21
Ovarian Strumal Carcinoid: Case Report, Systematic Literature Review and Pooled Analysis 21
Efficacy and Safety of Lanreotide Autogel and Temozolomide Combination Therapy in Progressive Thoracic Neuroendocrine Tumors (carcinoid): Results from the Phase 2 ATLANT Study 20
Taste Alterations Do Not Affect Change in Food Habits and Body Weight in Breast Cancer Patients 19
Sleep disturbances and restless legs syndrome in postmenopausal women with early breast cancer given adjuvant aromatase inhibitor therapy 13
Immune-related adverse events as potential surrogates of immune checkpoint inhibitors’ efficacy: a systematic review and meta-analysis of randomized studies 11
Is weight gain preventable in women with early breast cancer undergoing chemotherapy? A real-world study on dietary pattern, physical activity, and body weight before and after chemotherapy 11
Endocrine and Neuroendocrine Tumors: A Special Issue 9
Regression of advanced neuroendocrine tumors among patients receiving placebo 3
Totale 3.407
Categoria #
all - tutte 15.714
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.714


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019220 0 0 0 0 0 0 0 0 0 0 113 107
2019/2020898 97 32 37 89 64 115 108 103 87 96 28 42
2020/2021627 22 56 32 117 43 46 36 60 49 69 69 28
2021/2022303 40 24 17 10 4 20 3 29 13 35 18 90
2022/2023364 39 10 9 22 35 87 3 31 59 13 36 20
2023/2024366 32 13 50 22 26 78 17 21 92 11 4 0
Totale 3.407